Skip to main content

Myovant Sciences Ltd.

MYOVDelisted Mar 10, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001679082

Myovant Sciences Ltd. was delisted on Mar 10, 2023; its insiders filed their last Form 4 on Mar 10, 2023; 118 institutions reported holding it in 13F filings for Q4 2022, worth $1.12B in total; no superinvestor held it.

13F holders, Q1 2023

Institutional positions in Myovant Sciences Ltd. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

MYOV is no longer listed, and 13F filings after Q4 2022 list far fewer holders. See Q4 2022

Institutional holders
2
−116 vs. Q4 2022
Shares held
16
−41.7M (−100.0%) vs. Q4 2022
Total value
$27
−$1.12B (−100.0%) vs. Q4 2022
New holders
0
0 more added
Sold out
116
0 more reduced

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MYOV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 2 institutions
Q1 2021: 104 institutionsQ2 2021: 108 institutionsQ3 2021: 105 institutionsQ4 2021: 110 institutionsQ1 2022: 89 institutionsQ2 2022: 91 institutionsQ3 2022: 98 institutionsQ4 2022: 118 institutionsQ1 2023: 2 institutionsQ2 2023: 1 institutionQ3 2023: 1 institutionQ4 2023: 1 institutionQ1 2024: 1 institutionQ2 2024: 1 institutionQ3 2024: 1 institutionQ4 2024: 1 institutionQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ1 2023: $27
Q1 2021: $623.2MQ2 2021: $736.6MQ3 2021: $677.6MQ4 2021: $475.6MQ1 2022: $400.0MQ2 2022: $369.3MQ3 2022: $511.5MQ4 2022: $1.12BQ1 2023: $27Q2 2023: $27Q3 2023: $27Q4 2023: $27Q1 2024: $27Q2 2024: $27Q3 2024: $27Q4 2024: $27Q1 2025: $27Q2 2025: $27Q3 2025: $27Q4 2025: $27Q1 2026: $27Q2 2026: $27
Institutions holding MYOV and their total value by quarter
QuarterHoldersValue
Q2 20261$27
Q1 20261$27
Q4 20251$27
Q3 20251$27
Q2 20251$27
Q1 20251$27
Q4 20241$27
Q3 20241$27
Q2 20241$27
Q1 20241$27
Q4 20231$27
Q3 20231$27
Q2 20231$27
Q1 20232$27
Q4 2022118$1.12B
Q3 202298$511.5M
Q2 202291$369.3M
Q1 202289$400.0M
Q4 2021110$475.6M
Q3 2021105$677.6M
Q2 2021108$736.6M
Q1 2021104$623.2M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Myovant Sciences Ltd.; share changes are against Q4 2022.

Institutions holding MYOV in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Royal Bank of Canada0$00.00%−2,456−100.0%Sold out
Deutsche Bank AG0$00.00%−2,276−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−659−100.0%Sold out
Belpointe Asset Management LLC0$00.00%−560−100.0%Sold out
Harbour Investments, Inc.0$00.00%−440−100.0%Sold out
Advisory Services Network, LLC0$00.00%−300−100.0%Sold out
Crewe Advisors LLC0$00.00%−269−100.0%Sold out
CWM, LLC0$00.00%−205−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−90−100.0%Sold out
Newbridge Financial Services Group, Inc.0$00.00%−88−100.0%Sold out
Allworth Financial LP0$00.00%−53−100.0%Sold out
JFS Wealth Advisors, LLC0$00.00%−5−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−5−100.0%Sold out
Schubert & Co0$00.00%−3−100.0%Sold out
Disciplined Investments, LLC0$00.00%−2−100.0%Sold out
SJS Investment Consulting Inc.0$00.00%−1−100.0%Sold out
GWM Advisors LLC0$00.00%−91−100.0%Sold out
Steward Financial Group LLC0$00.00%−2−100.0%Sold out